Gender gap in reproductive preservation in cancer patients

Share this article:
Gender Gap in Reproductive Preservation in Cancer Patients
Gender Gap in Reproductive Preservation in Cancer Patients

(HealthDay News) -- A gender gap exists in the manner in which young adult cancer patients are presented with fertility preservation options, with women reporting fewer discussions of future reproductive choices, according to a study published online May 30 in BJOG: An International Journal of Obstetrics and Gynaecology.

In an effort to identify themes regarding perceptions of reproductive choices, Valerie L. Peddie, from the University of Aberdeen in the United Kingdom, and colleagues conducted interviews and analyzed participant responses in young adults diagnosed with cancer (16 men and 18 women, aged 17 to 49 years).

The researchers found that the primary barriers to pursuing fertility preservation were the urgency of treatment and the manner in which staff conveyed information. In all of the interviews, survival was viewed as paramount, with future fertility secondary. The majority of men stored sperm as "insurance" against future infertility, and sperm banking was viewed as "part and parcel" of oncology care. However, few women were presented with their options, reflecting clinicians' reservations about the experimental nature of egg and ovarian tissue cryopreservation and the need for partner involvement in storage of embryos.

"Significant gaps in the information provided to young women diagnosed with cancer suggest the need for an early appointment with a fertility expert," the authors write. "The findings of this study need to be replicated in a larger more representative population before the results can be used to inform a care pathway in the area of onco-fertility."

Abstract
Full Text (subscription or payment may be required)

This article originally appeared here.
Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Daily Oncology News

Challenges exist in treating HPV oropharyngeal cancer patients

Challenges exist in treating HPV oropharyngeal cancer patients

Mixed views have been expressed in relation to explaining the causal role of HPV in oropharyngeal cancer.

Views on Affordable Care Act split by political affiliation

Views on Affordable Care Act split by political ...

Health care is third most important issue to Americans in fall elections, according to polls

Poor staging linked to mortality in bladder cancer

Poor staging linked to mortality in bladder cancer

In cases of bladder cancer, omission of muscle in specimen or its mention in pathology report is linked to increased mortality.